ABEO (Abeona Therapeutics) Cyclically Adjusted FCF per Share: $-15.74 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ABEO Abeona Therapeutics Inc ABEO
32 GF Score
Price $7.45
! 8 Warning Signs
View Full Analysis

What is Abeona Therapeutics Cyclically Adjusted FCF per Share?

Abeona Therapeutics ABEO +2.90% 32 Cyclically Adjusted FCF per Share is $-15.74 as of Mar. 2026. GuruFocus rates ABEO with a GF Score™ of 32/100. The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Abeona Therapeutics's adjusted free cash flow per share for the three months ended in Mar. 2026 was $-0.366. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-15.74 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 3.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 28.00% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 34.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Abeona Therapeutics was 50.50% per year. The lowest was 3.60% per year. And the median was 27.30% per year.

As of today (2026-08-10), Abeona Therapeutics's current stock price is $7.445. Abeona Therapeutics's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $-15.74. Abeona Therapeutics's Cyclically Adjusted Price-to-FCF of today is .


Abeona Therapeutics  (NAS:ABEO) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Abeona Therapeutics Cyclically Adjusted FCF per Share Related Terms


Abeona Therapeutics Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Abeona Therapeutics's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abeona Therapeutics Cyclically Adjusted FCF per Share Chart

Abeona Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -41.25 -17.51 -18.45 -16.50 -15.70

Abeona Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.22 -16.15 -16.03 -15.70 -15.74

ABEO vs RCKT, UPB, PALI: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Abeona Therapeutics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abeona Therapeutics Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abeona Therapeutics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Abeona Therapeutics's Cyclically Adjusted Price-to-FCF falls into.


ABEO
32GF Score
Abeona Therapeutics Inc ABEO
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abeona Therapeutics Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Abeona Therapeutics's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.366/330.2130*330.2130
=-0.366

Current CPI (Mar. 2026) = 330.2130.

Abeona Therapeutics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -2.473 241.018 -3.388
201609 -3.108 241.428 -4.251
201612 -2.249 241.432 -3.076
201703 -3.684 243.801 -4.990
201706 -3.099 244.955 -4.178
201709 -4.237 246.819 -5.669
201712 -3.149 246.524 -4.218
201803 -4.030 249.554 -5.333
201806 -6.577 251.989 -8.619
201809 -5.595 252.439 -7.319
201812 -14.536 251.233 -19.106
201903 -8.501 254.202 -11.043
201906 -9.942 256.143 -12.817
201909 -9.648 256.759 -12.408
201912 -4.295 256.974 -5.519
202003 -3.711 258.115 -4.748
202006 -2.704 257.797 -3.464
202009 -2.958 260.280 -3.753
202012 -0.442 260.474 -0.560
202103 -3.722 264.877 -4.640
202106 -2.987 271.696 -3.630
202109 -2.736 274.310 -3.294
202112 -7.995 278.802 -9.469
202203 -2.380 287.504 -2.734
202206 -1.552 296.311 -1.730
202209 -1.058 296.808 -1.177
202212 -0.791 296.797 -0.880
202303 -0.708 301.836 -0.775
202306 -0.573 305.109 -0.620
202309 -0.233 307.789 -0.250
202312 -0.361 306.746 -0.389
202403 -0.559 312.332 -0.591
202406 -0.261 314.175 -0.274
202409 -0.263 315.301 -0.275
202412 -0.353 315.605 -0.369
202503 -0.398 319.799 -0.411
202506 -0.325 322.561 -0.333
202509 -0.437 324.800 -0.444
202512 -0.284 324.054 -0.289
202603 -0.366 330.213 -0.366

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-15.74 mean?
Abeona Therapeutics (ABEO) has a Cyclically Adjusted FCF per Share of $-15.74 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Abeona Therapeutics and its competitors.
Is Abeona Therapeutics' Cyclically Adjusted FCF per Share too high?
Abeona Therapeutics' current Cyclically Adjusted FCF per Share is $-15.74. Overall, Abeona Therapeutics has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Abeona Therapeutics' Cyclically Adjusted FCF per Share compare to RCKT and UPB?
Abeona Therapeutics' Cyclically Adjusted FCF per Share of $-15.74 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Abeona Therapeutics and its competitors. Abeona Therapeutics's current Cyclically Adjusted FCF per Share is $-15.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abeona Therapeutics stock overvalued right now?
Abeona Therapeutics (ABEO) has a current Cyclically Adjusted FCF per Share of $-15.74. The current Cyclically Adjusted FCF per Share is $-15.74. Abeona Therapeutics' overall GF Score™ is 32/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Abeona Therapeutics (ABEO), the current Cyclically Adjusted FCF per Share is $-15.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Abeona Therapeutics Business Description

Other Exchanges 0H7R:UKPCJ:Germany
Address 6555 Carnegie Avenue, 4th Floor, Cleveland, OH, USA, 44103
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
32GF Score

Get the complete analysis for ABEO

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.45
Price